Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jan;32(1):36-41.
doi: 10.1097/MCA.0000000000000945.

Characteristics of recurrent in-stent restenosis after second- and third-generation drug-eluting stent implantation

Affiliations

Characteristics of recurrent in-stent restenosis after second- and third-generation drug-eluting stent implantation

Hirokazu Shimono et al. Coron Artery Dis. 2021 Jan.

Abstract

Background: In second- and third-generation drug-eluting stent (DES) era, in-stent restenosis (ISR) is not commonly seen. However, a few patients still need repeat revascularizations for recurrent ISR even after second- and third-generation DES implantation.

Methods: From January 2012 to March 2017, 2339 lesions underwent second- and third-generation DES (Nobori, Promus Element, Resolute Integrity, Xience, Ultimaster and Synergy) implantation, of which 95 lesions (4.1%) underwent revascularization for first ISR. All lesions were divided into two groups of recurrent ISR group and non-recurrent ISR group. After successful optical coherence tomography (OCT) guided revascularization for all lesions, we investigated characteristics of recurrent ISR, and 2 years follow-up were completed.

Results: The mean age was 70.8 ± 11.7 years, and 73.2% were males. Among 56 DES-ISR lesions which were assessed by OCT, recurrent ISR was seen in 33.9% (N = 19) at 2 years follow-up after revascularization for first ISR. Serum low-density lipoprotein-cholesterol (LDL-C) level was higher in recurrent ISR group compared with non-recurrent ISR group (114.1 ± 53.9 mg/dl vs. 90.9 ± 27.8 mg/dl, P = 0.04) and heterogeneous tissue pattern was more frequently found in recurrent ISR group compared with non-recurrent ISR group (63.2% vs. 27.0%, P = 0.03). Multivariate analysis identified a heterogeneous tissue pattern (odds ratio 3.71; 95% confidence interval 1.09-12.59; P = 0.03) as an independent predictor of recurrent restenosis.

Conclusion: Recurrent ISR of second- and third-generation DES was associated with heterogeneous tissue pattern of first ISR, and high LDL-C level was associated with recurrence.

PubMed Disclaimer

References

    1. Misumida N, Kobayashi A, Kim SM, Abdel-Latif A, Ziada KM. Role of routine follow-up coronary angiography after percutaneous coronary intervention–systematic review and meta-analysis. Circ J. 2017; 82:203–210
    1. Yamaguchi H, Arikawa R, Takaoka J, Miyamura A, Atsuchi N, Ninomiya T, et al. Association of morphologic characteristics on optical coherence tomography and angiographic progression patterns of late restenosis after drug-eluting stent implantation. Cardiovasc Revasc Med. 2015; 16:32–35
    1. Gonzalo N, Serruys PW, Okamura T, van Beusekom HM, Garcia-Garcia HM, van Soest G, et al. Optical coherence tomography patterns of stent restenosis. Am Heart J. 2009; 158:284–293
    1. Arikawa R, Yamaguchi H, Takaoka J, Miyamura A, Atsuchi N, Ninomiya T, et al. Simple balloon dilation for drug-eluting in-stent restenosis: an optical coherent tomography analysis. Cardiovasc Revasc Med. 2015; 16:27–31
    1. Kajiya T, Yamaguchi H, Takaoka J, Fukunaga K, Arima R, Miyamura A, et al. In-stent restenosis assessed with frequency domain optical coherence tomography shows smooth coronary arterial healing process in second-generation drug-eluting stents. Singapore Med J. 2019; 60:48–51

MeSH terms

Substances